ENGAUGE Trademark

Trademark Overview


On Thursday, December 29, 2016, a trademark application was filed for ENGAUGE with the United States Patent and Trademark Office. The USPTO has given the ENGAUGE trademark a serial number of 87284044. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 6, 2017. This trademark is owned by Coalesce Medcom, LLC. The ENGAUGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing website featuring non-downloadable software for the pharmaceutical and biotech industries, namely, software to assist them when selecting Key Opinion Leaders or KOLs (KOL is a term used in this industry to refer to more influential healthcare providers) as a consultant, to participate at advisory meetings, to speak on their behalf, or to provide medical writing support. Pharmaceutical and biotech industries have no current methodology to select KOLs to support their communication offerings beyond selecting them based on hope that the opinion leader will perform to their standards. This software utilizes a 250+ point assessment to more adequately inform the pharmaceutical and biotech industry of the opinion leaders specific experiences with these communication offerings, research interests, and knowledge of the disease state to better inform KOL selection for these activities. The term ENGAUGE was selected because the data for each KOL is shown on a 5 point gauge indicating th...
engauge

General Information


Serial Number87284044
Word MarkENGAUGE
Filing DateThursday, December 29, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, November 6, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding website featuring non-downloadable software for the pharmaceutical and biotech industries, namely, software to assist them when selecting Key Opinion Leaders or KOLs (KOL is a term used in this industry to refer to more influential healthcare providers) as a consultant, to participate at advisory meetings, to speak on their behalf, or to provide medical writing support. Pharmaceutical and biotech industries have no current methodology to select KOLs to support their communication offerings beyond selecting them based on hope that the opinion leader will perform to their standards. This software utilizes a 250+ point assessment to more adequately inform the pharmaceutical and biotech industry of the opinion leaders specific experiences with these communication offerings, research interests, and knowledge of the disease state to better inform KOL selection for these activities. The term ENGAUGE was selected because the data for each KOL is shown on a 5 point gauge indicating their level of experience and level of risk when ENGAGING these KOLs to support specific offerings

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCoalesce Medcom, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSaratoga Springs, NY 12866

Trademark Events


Event DateEvent Description
Monday, November 6, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, November 6, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 10, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 10, 2017FINAL REFUSAL E-MAILED
Monday, April 10, 2017FINAL REFUSAL WRITTEN
Wednesday, April 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 4, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 4, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 3, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 3, 2017NON-FINAL ACTION E-MAILED
Monday, April 3, 2017NON-FINAL ACTION WRITTEN
Monday, March 27, 2017ASSIGNED TO EXAMINER
Tuesday, January 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 2, 2017NEW APPLICATION ENTERED IN TRAM